CinCor Pharma, Inc.
DelistedCIK 1868734fmd_0Z7J7F7FFQZRN6CY5SZ6D1TFQ8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2022, 8 periods
| Line item | FY2020 | FY2021 |
|---|---|---|
| Research and development | 19 | 22 |
| Total operating expenses | 21 | 43 |
| Operating income | (21) | (43) |
| Other non-operating income (expense) | 1 | 8 |
| Net income | (22) | (50) |